RxDoctor Payments Data

Theodore Brown, MD

Physical Medicine & Rehabilitation · Kirkland, WANPI 1568416873

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $42,194 of the $61,764 with a category attached, or 68.3%. It is spread thinly across 44 manufacturers, the largest accounting for just 20.8%. Reporting peaked in 2019 at $20,989 and has fallen 92.0% since, to $1,689 in 2025. Among physical medicine & rehabilitation clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$61,764in general payments, 2019–2025

Across 322 payments — averaging $191.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • E.r. Squibb & Sons, L.L.C.$13K
  • Bristol Myers Squibb$12K
  • Sanofi$9K
  • Novartis$8K
  • Merck Kgaa$7K
  • Greenwich Biosciences, Inc.$7K
  • plus $6K from 38 others
$4,436,137in research payments, 2019–2025

Across 318 payments — averaging $13,950 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Novartis$2.2M
  • Genentech, Inc.$1M
  • TG Therapeutics, Inc.$387K
  • AbbVie$236K
  • Adamas Pharmaceuticals, Inc.$177K
  • Merck$148K
  • plus $245K from 5 others

What the payments were for

  • Consulting fees$8,50914%
  • Speaking & faculty fees$42,19468%
  • Travel & lodging$3,5716%
  • Food & beverage$7,03711%
  • Education$4541%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$61,764 in reported general payments places this provider in the 95th percentile of 260 physical medicine & rehabilitation providers in Washington.

See all physical medicine & rehabilitation providers in Washington

Medicare billing

Part B allowed, 2024
$36,376
Medicare patients
132
Services billed
462

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
CopaxoneGlatiramer Acetate38$214,952
Glatiramer Acetate45$167,846
GlatopaGlatiramer Acetate48$163,558
Teriflunomide51$103,104
Avonex Pen (4 Pack)Interferon Beta-1a12$98,674
Avonex (4 Pack)Interferon Beta-1a11$89,866
BafiertamMonomethyl Fumarate13$83,627
FingolimodFingolimod Hcl47$78,215
Dalfampridine ErDalfampridine86$30,173
Dimethyl Fumarate96$27,896
MyrbetriqMirabegron33$23,177
Baclofen229$6,600
GemtesaVibegron13$6,022
Modafinil93$4,782
Gabapentin198$4,192

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Teva Pharmaceuticals USA, Inc.Copaxone$224$214,95238 claims
BiogenAvonex (4 Pack)$116$89,86611 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 260 physical medicine & rehabilitation providers in Washington.

Other physical medicine & rehabilitation in Kirkland

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →